Ambu received the award for its single-use flexible endoscopes that are designed to make the devices safe, affordable and accessible. It has aView and aBox all-in-one video displays that eliminate the traditional video endoscopy tower size and expense to be more cost-efficient, compact and portable platforms.
Frost & Sullivan presents the Global New Product Innovation Award to companies that develop an innovative element in a product with “leading-edge technologies.” The award recognizes the value-added features/benefits of a product and an increased return on investment the device gives to customers, according to Frost & Sullivan.
“The aScope 4 Broncho portfolio features three sizes of bronchoscopes, ensuring clinicians have a suitable instrument for any of the varying ICU and OR procedures enabled by the aScope. The aScope 4 Broncho can also be utilized with the company’s proprietary integrated sampling system, the BronchoSampler, which is a safe, one-handed, one-clinician alternative for specimen sampling,” Pavel Zhebrouski, Best Practices research analyst, said in a news release. “Ambu looks to differentiate its device from reusable solutions while also adhering to strict reliability and quality standards of the CE and the US FDA and adapting to growing market demands for innovation.”
Single-use endoscopes are sterile and ready for use out of the package to eliminate the risk of patient cross-contamination. Reprocessing reusable scopes is tough – a bad situation because reprocessing failure can result in one person’s tissue or fluid remaining on the scope and going into someone else.
Ambu launched its first single-use flexible endoscope in 2009 and has since launched five new single-use endoscopy products for ENT, urology and gastroenterology. The company announced that it would quadruple its innovation pipeline over the next three years to launch more than 20 new flexible endoscopy products.
“A vital part of Ambu’s success is building strong and cooperative relationships with its customers and partners. It is on contract with all four major group purchasing organizations in the US. Its recent contract expansions gave 90% of US hospitals access to Ambu’s complete line of single-use endoscopes while 98% of US hospitals have access to Ambu’s rhinolaryngoscopes, bronchoscopes, and cystoscopes,” Zhebrouski said. “Ambu emphasizes building trust and credibility in the medical community and ensuring high-quality outcomes.”
Ambu’s aScope Duodeno disposable endoscope is just one of many single-use endoscope innovations that could save patient lives.
